Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Kalaris Therapeutics Inc | StockGist | StockGist

Companies
KLRS
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings KLRSSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Kalaris Therapeutics Inc

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001754068

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

0

Reporting Person

Kalaris Therapeutics, Inc.

Person Type

IA

CUSIP: 482929106

Key Facts

Shares Owned

0

Recent Filings

Kalaris Therapeutics Inc3 weeks ago

Kalaris Therapeutics Inc1 months ago

Kalaris Therapeutics Inc3 months ago

Kalaris Therapeutics Inc3 months ago

Kalaris Therapeutics Inc3 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice